对体GPCR结合部位及其潜在结合性的比较研究
Sonja Peter1,2, Lydia Siragusa3,4, Morgan Thomas1,5
1Computational Chemistry, Nxera Pharma U.K., Steinmetz Building, Granta Park, Cambridge CB21 6DG, United Kingdom.
Journal of chemical information and modeling
|October 23, 2024
概括
一个新的注释方案对G蛋白结合受体 (GPCR) 结合位点进行了分类,揭示了全联体的独特化学性质,并提高了药物发现潜力.
科学领域:
- 生物化学和结构生物学
- 药理学和药物发现
- 计算化学计算化学
背景情况:
- 越来越多的实验性G蛋白结合受体 (GPCR) 结构揭示了各种各样的全调节位.
- 针对这些全位的药物数量有限,需要对药物发现有更深入的理解.
- 现有的识别全位的方法需要系统的评估和标准化.
研究的目的:
- 引入一个系统的注释方案,用于结构性地分类GPCR结合站点.
- 评估GPCR结构上的不同结合点检测方法的性能.
- 描述全联体和结合点的化学性质,特别是外螺旋的结合点.
主要方法:
- 开发了一个基于受体类,跨膜螺旋连接和膜亚位的GPCR特定注释方案.
- 将该方案应用于107个具有小分子连接体的GPCR结构,确定了24个不同的全结位.
- 对比了三种结合部位检测方法 (BioGPS,SiteMap,FTMap) 并分析了连接体和结合部位的特性.
主要成果:
- 生物GPS表现出卓越的性能,在24个全位中确定了22个.
- 螺旋外的全位和体表现出明显的化学特征:浅口袋,低体积和素的丰富.
- 结合受体和连接体相似性证明有效的连接性评估.
结论:
- 开发的注释方案提供了一个标准化,客观的框架,用于在GPCR中比较全结位.
- 了解外螺旋部位和连接体的独特化学空间可以指导未来的药物设计工作.
- 这项研究提高了在药物开发中准GPCR全位的潜力.
相关概念视频
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Transducer Mechanism: G Protein–Coupled Receptors
1.9K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.9K
Ligand Binding Sites
12.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.7K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K


